US 10766869
Triazoles for the treatment of demyelinating dieases
granted A61KA61K31/4196A61K31/4439
Quick answer
US patent 10766869 (Triazoles for the treatment of demyelinating dieases) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/4196, A61K31/4439, A61K31/454, A61K31/496